Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine for fatigue in terminal cancer
NCT00034450Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in carnitine deficiency comparing L-carnitine with Placebo (2 arms). Primary endpoint: Change in fatigue at 4 weeks. Started Jan 2002; status: completed.
02
Drugs
levocarnitine
03
Conditions
carnitine deficiency
Beyond the preview
Go deeper on NCT00034450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034450.